Skip to main
CYRX

CryoPort (CYRX) Stock Forecast & Price Target

CryoPort (CYRX) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CryoPort is well positioned to benefit from the growing cell and gene therapy market, with a strong focus on providing temperature-controlled logistics services. The company has a robust customer base and a long runway for revenue growth, as evidenced by its expanding portfolio of supported therapies and clinical customers. With an increasing number of commercial approvals expected, CryoPort is likely to see strong revenue growth and further margin expansion. The company's strong financial performance and potential for future growth make it an attractive investment option in the life sciences industry.

Bears say

CryoPort is experiencing competition in the market and faces uncertainty in the advancement of cell and gene therapies, which may limit their revenue growth potential and negatively impact their financial outlook. Additionally, their current valuation is relatively high compared to their small/mid-cap growth and life sciences tools and diagnostics peers, which could lead to a decrease in stock price.

CryoPort (CYRX) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CryoPort (CYRX) Forecast

Analysts have given CryoPort (CYRX) a Strong Buy based on their latest research and market trends.

According to 6 analysts, CryoPort (CYRX) has a Strong Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CryoPort (CYRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.